Higher serum levels of apolipoprotein A1 were associated with lower prevalence of CKD and higher eGFR in two multi-ethnic populations, while a higher apolipoprotein B/A1 ratio was significantly associated with lower eGFR46. Here, APOA1 is linked to chronic kidney disease.